Open-label pilot study using hydroxytyrosol as dietary supplements in patients with mitochondrial diseases.

Orphanet J Rare Dis · 2025 · PMC12142884 · PMID 40481516

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Overall, the administration of HT demosntrated a possible trend in improvng the health QOL despite the lack of definite clinical improvement indicated by the IPMDS scores throughout the study.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.